Eli Lilly Will Offer Half-Priced Insulin Generic in U.S.

Drug Industry Daily
A A
As pressure continues to build on drugmakers to address high drug prices, Eli Lilly announced that it will market a half-priced generic of its Humalog insulin injection in the U.S.

To View This Article:

Login

Subscribe To Drug Industry Daily